NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding NextCure, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 41 | 43 | +2 |
| Shares | 12.9M | 13.3M | +446.6K (+3.5%) |
| Value | $16.6M | $15.3M | −$1.36M (−8.2%) |
New holders (7)
Institutions that held NextCure, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cable Car Capital LLC | 615,878 | $702.1K | 0.74% |
| ADAR1 Capital Management, LLC | 60,414 | $68.9K | 0.03% |
| Marquette Asset Management, LLC | 58,259 | $66.4K | 0.01% |
| Virtu Financial LLC | 26,550 | $30.0K | 0.00% |
| XTX Topco Ltd | 17,228 | $19.6K | 0.00% |
| LPL Financial LLC | 15,032 | $17.1K | 0.00% |
| Royal Bank of Canada | 265 | $0 | 0.00% |
Sold out (5)
Institutions that held NextCure, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| DAFNA Capital Management LLC | 166,185 | $214.4K |
| ExodusPoint Capital Management, LP | 20,449 | $26.0K |
| Susquehanna International Group, LLP | 13,094 | $16.9K |
| FMR LLC | 4,629 | $5.97K |
| State of Wyoming | 2,613 | $3.37K |